Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2014) 34 P59 | DOI: 10.1530/endoabs.34.P59

SFEBES2014 Poster Presentations Clinical practice/governance and case reports (103 abstracts)

Unexpected adrenocortical carcinoma 8 years after diagnosis of adrenal incidentaloma

Mahender Yadagiri & David Barton


Shrewsbury and Telford NHS Foundation Trust, Telford, UK.


Adrenal incidentalomas (AI) are incidentally discovered adrenal masses on imaging studies requested for reasons unrelated to adrenal pathology with a prevalence of 8% in autopsy and 4% in radiologic series. Although most AI are non-functioning benign adenomas, their increasing prevalence presents diagnostic and therapeutic challenges. We report a case of adrenocortical carcinoma (ACC) in an asymptomatic 83-year-old man, 8 years after being diagnosed with AI. ACC is an uncommon malignancy carrying a high mortality.

In accordance with current guidelines, the AI was followed up with sequential CT at intervals of 6, 12 and 24 months which measured 2.0 cm throughout. Biochemical testing revealed only incomplete cortisol suppression with low dose dexamethsaone. Some 8 years later, he had a staging CT in view of a non-healing tongue ulcer which showed a prominent right adrenal mass measuring up to 9.0 cm.

The radiological characteristics were suggestive of ACC and in addition a low attenuation lesion was identified in the liver. Repeat biochemistry showed persistent subclinical hypercortisolism and normal plasma catecholamines. Right laparoscopic adrenalectomy was performed with uncomplicated postoperative recovery. Six months later, he presented with haemoptysis and CT abdomen showed progressive liver metastases requiring chemotherapy (Mitotane). We have reviewed the guidelines from the literature including AAES and AACE (2009), ACR (2012), NIH (2002) which limit follow-up recommendations of small AI to 5 years.

The initial size of adrenal lesion would have hardly warranted surgical intervention on size criteria alone. This patient had subclinical cushings syndrome (SCS) but data from randomised trials are lacking to guide the optimal management of SCS. A postulated strategy is to consider adrenalectomy for younger patients (<40 years) and those with disorders that are potentially attributable to autonomous glucocorticoid secretion (recent onset or worsening of underlying hypertension, diabetes mellitus, obesity or osteoporosis).

Article tools

My recent searches

No recent searches.